The use of needle-free syringes to inject short-acting and rapid-acting insulin therapy can significantly shorten the time of onset of insulin, reverse the glycotoxic effect of hyperglycemia on β cells and significantly enhance the hypoglycemic effect (14). Here, INS is linked to Hyperglycemia.